The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neurosyphilis-Global Market Insights and Sales Trends 2024
Synopsis
Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
The global Neurosyphilis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neurosyphilis in various end use industries. The expanding demands from the Hospital & Clinics, Medical Research Centers and Academic Institutes,, are propelling Neurosyphilis market. Asymptomatic Neurosyphilis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningeal Neurosyphilis segment is estimated at % CAGR for the next seven-year period.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neurosyphilis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neurosyphilis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neurosyphilis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neurosyphilis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neurosyphilis covered in this report include Abbott, Bayer, Eli Lilly and Company, GlaxoSmithKline, Novartis, Pfizer and Sanofi, etc.
The global Neurosyphilis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Global Neurosyphilis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neurosyphilis market, Segment by Type:
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
Others
Global Neurosyphilis market, by Application
Hospital & Clinics
Medical Research Centers
Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neurosyphilis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
The global Neurosyphilis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neurosyphilis in various end use industries. The expanding demands from the Hospital & Clinics, Medical Research Centers and Academic Institutes,, are propelling Neurosyphilis market. Asymptomatic Neurosyphilis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningeal Neurosyphilis segment is estimated at % CAGR for the next seven-year period.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neurosyphilis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neurosyphilis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neurosyphilis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neurosyphilis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neurosyphilis covered in this report include Abbott, Bayer, Eli Lilly and Company, GlaxoSmithKline, Novartis, Pfizer and Sanofi, etc.
The global Neurosyphilis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Global Neurosyphilis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neurosyphilis market, Segment by Type:
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
Others
Global Neurosyphilis market, by Application
Hospital & Clinics
Medical Research Centers
Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neurosyphilis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neurosyphilis
1.1 Neurosyphilis Market Overview
1.1.1 Neurosyphilis Product Scope
1.1.2 Neurosyphilis Market Status and Outlook
1.2 Global Neurosyphilis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neurosyphilis Market Size by Region (2018-2029)
1.4 Global Neurosyphilis Historic Market Size by Region (2018-2023)
1.5 Global Neurosyphilis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neurosyphilis Market Size (2018-2029)
1.6.1 North America Neurosyphilis Market Size (2018-2029)
1.6.2 Europe Neurosyphilis Market Size (2018-2029)
1.6.3 Asia-Pacific Neurosyphilis Market Size (2018-2029)
1.6.4 Latin America Neurosyphilis Market Size (2018-2029)
1.6.5 Middle East & Africa Neurosyphilis Market Size (2018-2029)
2 Neurosyphilis Market by Type
2.1 Introduction
2.1.1 Asymptomatic Neurosyphilis
2.1.2 Meningeal Neurosyphilis
2.1.3 Meningovascular Neurosyphilis
2.1.4 Others
2.2 Global Neurosyphilis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neurosyphilis Historic Market Size by Type (2018-2023)
2.2.2 Global Neurosyphilis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neurosyphilis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neurosyphilis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neurosyphilis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neurosyphilis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neurosyphilis Revenue Breakdown by Type (2018-2029)
3 Neurosyphilis Market Overview by Application
3.1 Introduction
3.1.1 Hospital & Clinics
3.1.2 Medical Research Centers
3.1.3 Academic Institutes
3.2 Global Neurosyphilis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neurosyphilis Historic Market Size by Application (2018-2023)
3.2.2 Global Neurosyphilis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neurosyphilis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neurosyphilis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neurosyphilis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neurosyphilis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neurosyphilis Revenue Breakdown by Application (2018-2029)
4 Neurosyphilis Competition Analysis by Players
4.1 Global Neurosyphilis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurosyphilis as of 2022)
4.3 Date of Key Players Enter into Neurosyphilis Market
4.4 Global Top Players Neurosyphilis Headquarters and Area Served
4.5 Key Players Neurosyphilis Product Solution and Service
4.6 Competitive Status
4.6.1 Neurosyphilis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Neurosyphilis Products, Services and Solutions
5.1.4 Abbott Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Neurosyphilis Products, Services and Solutions
5.2.4 Bayer Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Eli Lilly and Company
5.3.1 Eli Lilly and Company Profile
5.3.2 Eli Lilly and Company Main Business
5.3.3 Eli Lilly and Company Neurosyphilis Products, Services and Solutions
5.3.4 Eli Lilly and Company Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Neurosyphilis Products, Services and Solutions
5.4.4 GlaxoSmithKline Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Neurosyphilis Products, Services and Solutions
5.5.4 Novartis Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Neurosyphilis Products, Services and Solutions
5.6.4 Pfizer Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Neurosyphilis Products, Services and Solutions
5.7.4 Sanofi Neurosyphilis Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
6 North America
6.1 North America Neurosyphilis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neurosyphilis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neurosyphilis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neurosyphilis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neurosyphilis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neurosyphilis Market Dynamics
11.1 Neurosyphilis Industry Trends
11.2 Neurosyphilis Market Drivers
11.3 Neurosyphilis Market Challenges
11.4 Neurosyphilis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
